TRXC TransEnterix

Asensus Surgical to Participate in the Oppenheimer 33rd Annual Healthcare Conference

Asensus Surgical to Participate in the Oppenheimer 33rd Annual Healthcare Conference

RESEARCH TRIANGLE PARK, N.C., March 06, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Anthony Fernando, President and Chief Executive Officer, and Shameze Rampertab, Executive Vice President and Chief Financial Officer, will participate in the Oppenheimer 33rd Annual Healthcare Conference. The Company’s virtual presentation will take place on Monday, March 13 at 2:00 pm Eastern Time.

The conference webcast will be available online on the investor relations page of the Company’s website at /events-and-presentations. Replays of the webcasts will be archived on the website for approximately 90 days.

About Asensus Surgical, Inc.

Asensus Surgical, Inc. is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™ by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. Based upon the foundations of Digital Laparoscopy and the Senhance® Surgical System, the Company is developing the LUNA™ Surgical System, a next generation robotic and instrument system as a foundation of its Digital Surgery solution. These systems will be powered by the Intelligent Surgical Unit to increase surgeon control and reduce surgical variability. With the addition of machine vision, Augmented Intelligence, and deep learning capabilities throughout the surgical experience, we intend to holistically address the current clinical, cognitive and economic shortcomings that drive surgical outcomes and value-based healthcare. The Senhance Surgical System is now available for sale in the US, EU, Japan, Russia, and select other countries. For a complete list of indications for use, visit: /indications. To learn more about Performance-Guided Surgery, Digital Laparoscopy with the Senhance Surgical System and the new LUNA System visit .

Follow Asensus

Email Alerts: /email-alerts

LinkedIn: /company/asensus-surgical-inc

Twitter: /AsensusSurgical

YouTube: /c/transenterix

Vimeo:

TikTok:

INVESTOR CONTACT:

Mark Klausner or Mike Vallie, 443-213-0499

MEDIA CONTACT:

Isabella Rodriguez, 708-833-1572

CG Life



EN
06/03/2023

Underlying

TRXCTransEnterix

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on TransEnterix

 PRESS RELEASE
Free
TRXC TRANSENTERIX

Asensus Surgical Announces Closing of Acquisition by KARL STORZ

Asensus Surgical Announces Closing of Acquisition by KARL STORZ KARL STORZ acquires US-headquartered company to create a surgical robotics hub and drive Perfomance-Guided Surgery™ RESEARCH TRIANGLE PARK, N.C. and TUTTLINGEN, Germany, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC) (“Asensus Surgical” or “Asensus”), a global leader of innovative digital solutions for the operating room, today announced the closing of the merger (the “Merger”) with the KARL STORZ Group (“KARL STORZ”). The transaction was completed following approval by the Asensus Surgical s...

August 22, 2024 1 EN
 PRESS RELEASE
Free
TRXC TRANSENTERIX

Asensus Surgical, Inc. Reports Operating and Financial Results for the...

Asensus Surgical, Inc. Reports Operating and Financial Results for the Second Quarter 2024 RESEARCH TRIANGLE PARK, N.C., Aug. 13, 2024 (GLOBE NEWSWIRE) -- , Inc. (NYSE American: ASXC), a global leader of innovative digital solutions for the operating room, announced its operating and financial results for the second quarter 2024. Recent Highlights Announced a definitive merger agreement (the “Merger Agreement”) with KARL STORZ Endoscopy-America, Inc. ("KARL STORZ"), a wholly owned direct subsidiary of KARL STORZ SE & Co. KG, an independent, family-owned global medical technology company...

August 13, 2024 1 EN
 PRESS RELEASE
Free
TRXC TRANSENTERIX

Asensus Surgical, Inc. Schedules Second Quarter Financial and Operatin...

Asensus Surgical, Inc. Schedules Second Quarter Financial and Operating Results Conference Call for August 13, 2024 RESEARCH TRIANGLE PARK, N.C., Aug. 08, 2024 (GLOBE NEWSWIRE) -- , Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient, announced today that it plans to release 2024 second quarter financial and operating results after the market closes on Tuesday, August 13, 2024. The Company will host a conference call to discuss these results and the status of the proposed merger with KARL STORZ starting at 4:30 p.m. ET ...

August 8, 2024 1 EN
 PRESS RELEASE
Free
TRXC TRANSENTERIX

Asensus Surgical 2024 Special Meeting of Stockholders Is Adjourned

Asensus Surgical 2024 Special Meeting of Stockholders Is Adjourned RESEARCH TRIANGLE PARK, N.C., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a global leader of innovative digital solutions for the operating room, today announced that the Company’s Special Meeting of Stockholders, scheduled to be held on Wednesday, August 7, 2024 at 10:00 a.m. (Eastern Time), was adjourned to Tuesday, August 20, at 10:00 a.m. (Eastern Time). The Special Meeting will be held virtually. While we have received proxies for approximately 52% of our outstanding shar...

August 7, 2024 1 EN
 PRESS RELEASE
Free
TRXC TRANSENTERIX

Independent Proxy Advisory Firm ISS Recommends Asensus Surgical Stockh...

Independent Proxy Advisory Firm ISS Recommends Asensus Surgical Stockholders Vote “FOR” the Pending Merger with KARL STORZ RESEARCH TRIANGLE PARK, N.C., July 30, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a global leader of innovative digital solutions for the operating room, announced today that leading independent proxy advisory firm, Institutional Shareholder Services Inc. (“ISS”), became the second advisory firm to recommend that Asensus Surgical stockholders vote “FOR” all proposals relating to the pending merger transaction with KARL STORZ Endoscopy-Ameri...

July 30, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch